Key facts
- It has raised $1.4M; the latest was Seed Round ($1.4M) in Feb 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Energrowth
- ·The full record, as it builds
Funding rounds
No funding rounds for Energrowth are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Energrowth
Developer of nutritional supplements designed for health. The company's products mainly focus on γ-aminobutyric acid L-lysine multivitamin nutritional mineral tablets, DHA algae oil ARA gel candy, etc., providing customers with reliable and innovative products.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Shenzhen, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Energrowth doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Energrowth shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Energrowth in its N-PORT filings yet. We sweep new filings monthly.